The combination of sofosbuvir and daclatasvir is effective and safe in treating patients with hepatitis C and severe renal impairment

Effectiveness, treatment completion and safety of sofosbuvir/ledipasvir and paritaprevir/ritonavir/ombitasvir + dasabuvir in patients with chronic kidney disease: an ERCHIVES study

(2018) A. A. Butt et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

OUP accepted manuscript

(2018)   CLINICAL INFECTIOUS DISEASES

Low-Dose Sofosbuvir Is Safe and Effective in Treating Chronic Hepatitis C in Patients with Severe Renal Impairment or End-Stage Renal Disease

(2018) Sunil Taneja et al.   DIGESTIVE DISEASES AND SCIENCES

Higher risk of renal disease in chronic hepatitis C patients: Antiviral therapy survival benefit in patients on hemodialysis

(2018) Jonas Söderholm et al.   JOURNAL OF HEPATOLOGY

Efficacy and safety of direct-acting antivirals-based antiviral therapies for hepatitis C virus patients with stage 4-5 chronic kidney disease: a meta-analysis

(2017) Tao Li et al.   LIVER INTERNATIONAL

Glecaprevir and Pibrentasvir in Patients with HCV and Severe Renal Impairment

(2017) Edward Gane et al.   NEW ENGLAND JOURNAL OF MEDICINE

Pharmacokinetics, safety and efficacy of a full dose sofosbuvir-based regimen given daily in hemodialysis patients with chronic hepatitis C

(2016) Aude Desnoyer et al.   JOURNAL OF HEPATOLOGY

Safety and efficacy of sofosbuvir-containing regimens in hepatitis C-infected patients with impaired renal function

(2016) Varun Saxena et al.   LIVER INTERNATIONAL

Safety, efficacy and tolerability of half-dose sofosbuvir plus simeprevir in treatment of Hepatitis C in patients with end stage renal disease

(2015) Bhamidimarri Kalyan Ram et al.   JOURNAL OF HEPATOLOGY

Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4–5 chronic kidney disease (the C-SURFER study): a combination phase 3 study

(2015) David Roth et al.   LANCET

Hepatitis C virus infection in end-stage renal disease and kidney transplantation

(2014) Patrizia Burra et al.   TRANSPLANT INTERNATIONAL

Meta-analysis of observational studies: hepatitis C and survival after renal transplant

(2013) F. Fabrizi et al.   JOURNAL OF VIRAL HEPATITIS

Hepatitis C virus itself is a causal risk factor for chronic kidney disease beyond traditional risk factors: a 6-year nationwide cohort study across Taiwan

(2013) Yi-Chun Chen et al.   BMC Nephrology